Bausch Health

Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures, and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology, and branded generics.

History

Bausch Health was founded in 1959 by Milan Puskar and Don Panoz. In 2010, the company was acquired by Valeant Pharmaceuticals, a Canadian-based multinational pharmaceutical company. In 2018, Valeant changed its name to Bausch Health Companies Inc.

Products

Bausch Health's product portfolio includes both pharmaceutical and medical device products. These include prescription brands, branded generics, over-the-counter (OTC) products, medical devices, and biologic products.

Operations

Bausch Health operates through several business units: Bausch + Lomb, Salix Pharmaceuticals, Ortho Dermatologics, and Diversified Products. The company has operations in more than 100 countries and its products are sold in approximately 100 countries.

Financials

Bausch Health reported revenues of $8.6 billion in 2019. The company's largest segment, Bausch + Lomb, accounted for nearly half of the total revenue.

Controversies

Bausch Health has been involved in several controversies, including allegations of price gouging, anticompetitive behavior, and accounting irregularities. In 2015, the company faced a major scandal when it was revealed that it had been using a specialty pharmacy, Philidor Rx Services, to inflate its sales and earnings.

See also

• Pharmaceutical industry in Canada
• List of pharmaceutical companies

   This article is a pharmacology-related stub. You can help WikiMD by expanding it!